Time course of platelet counts in critically ill patients.
about
Coagulation abnormalities in critically ill patientsThe potential of antimicrobials to induce thrombocytopenia in critically ill patients: data from a randomized controlled trialHow do we approach thrombocytopenia in critically ill patients?Etiology and clinical relevance of elevated platelet count in ICU patients : A retrospective analysis.Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.Bench-to-bedside review: thrombocytopenia-associated multiple organ failure--a newly appreciated syndrome in the critically illOutcome of life-threatening malaria in African children requiring endotracheal intubation.Effect of Drotrecogin alfa (activated) on platelet receptor expression in vitro.Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failurePlatelet counts and outcome in the pediatric intensive care unit.Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.Thrombocytopenia in the pediatric burn patient.Postoperative failure of platelet recovery is an independent risk factor for poor survival in patients with oral and oropharyngeal cancer.Platelet and mean platelet volume kinetics in adult patients with sepsis.A Case of Thrombocytopenia due to Odontogenic Infection.The incidence, causes, and prognostic significance of new-onset thrombocytopenia in intensive care units: a prospective cohort study in a Korean hospital.Epidemiology and outcome of thrombocytopenic patients in the intensive care unit: results of a prospective multicenter study.Prospective observational evaluation of the particle immunofiltration anti-platelet factor 4 rapid assay in MICU patients with thrombocytopenia.Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway.Comparative evaluation of thrombocytopenia in adult patients receiving linezolid or glycopeptides in a respiratory intensive care unit.Platelet mitochondrial membrane depolarization reflects disease severity in patients with sepsis and correlates with clinical outcomeUse of therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure in the Turkish thrombocytopenia-associated multiple organ failure network.Clinical significance of platelet-associated hematological parameters as an early supplementary diagnostic tool for sepsis in thrombocytopenic very-low-birth-weight infants.Thrombocytopenia impairs host defense in gram-negative pneumonia-derived sepsis in mice.Mechanisms and etiologies of thrombocytopenia in the intensive care unit: impact of extensive investigationsThrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome.Effect of Persistent Thrombocytopenia on Mortality in Surgical Critical Care Patients: A Retrospective Study.Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury.The Incidence, Clinical Outcomes, and Risk Factors of Thrombocytopenia in Intra-Abdominal Infection Patients: A Retrospective Cohort Study.Interleukin-18 and miR-130a in severe sepsis patients with thrombocytopeniaThrombocytopaenia during methicillin-sensitive Staphylococcus aureus bacteraemia.Platelets and infections in the resource-limited countries with a focus on malaria and viral haemorrhagic fevers.Multiple organ failure and outcome of critically ill patients with haematological malignancy.An increase in mean platelet volume from baseline is associated with mortality in patients with severe sepsis or septic shock.Thrombocytosis after hip and knee surgery in the rehabilitation setting: is it an occasional phenomenon? Relationship with deep venous thrombosis and functional outcomeCurrent understanding of disseminated intravascular coagulation.Attenuated platelet aggregation in patients with septic shock is independent from the activity state of myosin light chain phosphorylation or a reduction in Rho kinase-dependent inhibition of myosin light chain phosphatase.Assessment of Haemostasis in Disseminated Intravascular Coagulation by Use of Point-of-Care Assays and Routine Coagulation Tests, in Critically Ill Patients; A Prospective Observational StudyBlockade of Thrombopoietin Reduces Organ Damage in Experimental Endotoxemia and Polymicrobial Sepsis
P2860
Q28199912-303C1777-ED10-4588-B9D7-C53440B7220DQ28535471-1768751E-5EE3-4AE7-B227-FC9316367DD5Q30240053-9F46825B-2737-4E7E-926C-AB6CDC131F42Q30313293-819AC006-69A2-4DC1-8C54-CAEA30DA6CD6Q33358278-3E2C3002-4DAC-4BCE-85A6-1524EED2CEE9Q33372452-13B833C8-62F4-48BC-B8D4-B3789041B200Q33373238-CC80137E-D004-47F7-B786-C753B63CAF28Q33375080-111A17D1-FCB1-4F6F-9362-F7C493948C2DQ33375997-F2334D4B-7367-421A-949D-171E69CB6507Q33381364-C1FEB420-7DDB-4FB5-95F2-FCE58A6EE8B9Q33386170-EF242E87-7B3D-4614-B4F1-29AF4F1B75CEQ33389707-C035E0F2-3290-4339-8FE5-33F37DFB3927Q33394588-9A32361E-6860-4E2F-A3E9-AD8506DAE11EQ33401487-80EFA771-6828-4C87-8C13-5D0D8A0CEDDBQ33401962-ABC769F2-D0C1-4434-A61E-F4E65A4C0E7CQ33403404-1C5B31CE-439A-4C33-989B-96877F3D62CBQ33404467-E910EC54-D185-46FC-BFEC-D338BB5207C6Q33408219-26206CA8-C316-490F-9A8F-C1D704F15B2AQ33409277-C1689A9C-8F22-4D50-96DD-121D7A39A610Q33411077-C15B55D2-FB72-4273-A2C5-B63637AD5D51Q33412500-3646E8A5-D247-4371-9E2B-C561DF0C86EDQ33413307-196B2120-AECD-4292-8C3B-37EF1F7B73B0Q33416769-A5AAB894-F627-4196-AE9F-02CD15F9FD3EQ33417952-571934B3-2898-4546-B126-35F157C5C30AQ33418094-4AAE5FF4-0243-4A62-9C10-AC1F5DCEB705Q33419810-67CB0580-B1EC-4328-B202-18A66090DA45Q33421465-FF413664-E9E8-4576-A123-D1FC59EEE12CQ33423231-0B887657-768B-49CC-A275-7A2DBFFEECA4Q33426245-36706020-ED18-47F9-8693-6D08A61DEEB4Q33429486-26A520FE-7A74-4E9F-A01A-3F122F3349CAQ33431216-9A738C0A-0595-4E49-A8E9-9D9A81FBA573Q33437851-D694795E-A5B0-433C-BB27-42F423E5DF13Q33440142-80638249-7447-4658-9C0F-B8D08865FE15Q35089209-1DE89FF7-BB39-4D00-A42D-50B9093A88DFQ35151692-7080C9F1-C600-458B-86E3-10D040A2D612Q35493448-7ACB5B06-4E17-44EA-9DE3-6D0E06B61E33Q35661014-CE95DAC9-7878-4A8E-B334-4778EB33BBBDQ35883533-5D744F98-448F-449E-81A5-69831ABD6BE1Q35951277-7BE113BF-E387-48AF-9576-0E49374BBB8DQ35952453-B7E53782-CEBE-4A2A-A476-34E0E884E3B0
P2860
Time course of platelet counts in critically ill patients.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Time course of platelet counts in critically ill patients.
@ast
Time course of platelet counts in critically ill patients.
@en
type
label
Time course of platelet counts in critically ill patients.
@ast
Time course of platelet counts in critically ill patients.
@en
prefLabel
Time course of platelet counts in critically ill patients.
@ast
Time course of platelet counts in critically ill patients.
@en
P2093
P1476
Time course of platelet counts in critically ill patients
@en
P2093
Arnaldo de Mendonça
Marcel Levi
Peter Suter
Philip Haji-Michael
Serdar Akca
P304
P356
10.1097/00003246-200204000-00005
P407
P577
2002-04-01T00:00:00Z